| LT | Liver Transplantation |
| ALF | Acute Liver Failure |
| WL | Waiting List |
| BTs | Bridging Therapies |
| MOSF | Multiorgan System Failure |
| INR | International Normalized Ratio |
| DAMPs | Damage-Associated Molecular Patterns |
| CRRT | Continuous Renal Replacement Therapy |
| LxT | Liver Xenotransplantation |
| NHP | Non-Human Primate |
| FK506 | Tacrolimus |
| HBV | Hepatitis B Virus |
| HAR | Hyperacute Rejection |
| GGTA1 | α-1,3-galactosyltransferase gene |
| GTKO | α-1,3-galactosyltransferase gene-knockout |
| Neu5Gc | N-glycolylneuraminic acid |
| CMAH | Cytidine monophospho-N-acetylneuraminic acid hydroxylase |
| β4GalNT2 | β-1,4-N-acetylgalactosaminyl transferase 2 |
| Sd(a) | DBA-reactive glycans |
| TKO | Triple-Knockout |
| hTBM | Human Thrombomodulin |
| hEPCR | Human Endothelial Protein C Receptor |
| vWF | Von Willebrand Factor |
| xTMA | Xenograft thrombotic microangiopathy |
| IVC | Inferior Vena Cava |
| ALT | Alanine aminotransferase |
| AST | Aspartate aminotransferase |
| aPTT | Activated partial thromboplastin time |
| LSEC | Liver sinusoidal endothelial cell |
| SEM | Scanning electron microscopy |
| PERV | Porcine endogenous retrovirus |
| PCMV | Porcine cytomegalovirus |
| ELC | Extracorporeal Liver Cross-Circulation |
| TNFAIP3 | Tumor necrosis factor alpha-induced protein 3 |
| HMOX1 | Heme Oxygenase 1 |
| HCC | Hepatocellular carcinoma |
| MMF | Mycophenolate mofetil |
| PLHV1 | Porcine lymphotropic herpesvirus-1 |
| PRRSV | Porcine reproductive and respiratory syndrome virus |
| ACLF | Acute-on-chronic liver failure |
| PCV3 | Porcine circovirus type 3 |
| iPSC | Induced pluripotent stem cells |